Element Science, an innovative health technology company pioneering a digital wearable platform that monitors and protects high-risk cardiovascular patients, announces that its Jewel® Wearable Patch Cardioverter Defibrillator (Jewel) has received the prestigious Red Dot Design Award. This award signals international recognition of Jewel's unique design, focusing on patient comfort while delivering continuous protection from temporary periods of elevated Sudden Cardiac Arrest (SCA) ris

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the closing of its deal to acquire BELKIN Vision with a total upfront consideration of $81M, including a cash payment of approximately $65M. The deal also includes the potential for up to $385M in payments, contingent upon rigorous sales-based milestones. The acquisition includes BELKIN Vision’s Direct Selective Laser Trabeculoplasty (DSLT) technology, expanding Alcon’

Trivitron Healthcare, a leading global medical technology company, proudly announces the launch of its state-of-the-art CT scanner, branded as “Terrene.” This ground-breaking technology is the first of its kind in India to receive approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB) and Central Drugs Standard Control Organization (CDSCO), marking a significant milestone in the Indian healthcare industry. The aim of Terrene CT sca

Astria Health is proud to announce the ground breaking event for the Behavioral Health Unit expansion at Astria Toppenish Hospital (ATH). This expansion is a significant milestone in our commitment to mental health needs in the State of Washington. With strong support from legislators, community partners, local government and businesses, 100% of the required $13.1 million has been secured to complete the new unit. Since 2017, the Washington State Health Care Authority has been addressing the

Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it recently participated in a Virtual Investor “What This Means” segment. For the segment, Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discussed the current standard of care for people with

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability and speed problems, today announced that

Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 100% pediatric patient enrollment at burn centers for its 2024 pivotal study designed to validate the AI-driven algorithm used by its DeepView™ System for its burn indication. This pivotal study is scheduled to be comp

Alpha Capital Anstalt, a prominent investor known for its successful ventures in the United States and globally, has finalized the acquisition of all operating assets and IP of ENvizion Medical Ltd., including ENvizion Medical Inc., based in Arlington Heights, Illinois, USA. Following this transaction, ENvizion Medical Inc. will operate as a privately held entity, independent from its former parent company, ENvizion Medical Ltd., which was previously publicly traded on the Tel Aviv

uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has entered into an agreement for the sale of its global manufacturing facility in Lexington, Massachusetts to Genezen, a leading contract development and manufacturing organization specializing in the supply of retroviral vectors, lentiviral vectors, and adeno-associated virus (AAV) technologies. Genezen agreed to acquire uniQure&rsquo

Artivion, Inc. a leading cardiac and vascular surgery company focused on aortic disease, today announced it has amended its credit facility and option purchase agreements with Endospan Ltd. ("Endospan"), an Israeli-based, privately-held developer of the NEXUS® Stent Graft System ("NEXUS"). In 2019, the Company provided a credit facility to Endospan and entered into an option agreement to purchase Endospan upon U.S. Food and Drug Administration ("FDA") ap